Performance analysis of Drugs Made In America Acquisition II Corp - Units (1 Ord Shs & 1 Rts) (DMIIU)
Annual Return
Since Sep 25, 2025, DMIIU has had an average annual return of +1.83%, underperforming the benchmark SPY, which returned +18.17% annual.
| 2026 | 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +1.25% | +0.25% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.35% | +0.30% | -0.40% | +0.20% | +0.94% | +0.05% | -0.20% | +1.25% | |||||
| 2025 | -0.45% | +0.90% | -0.20% | +0% | +0.25% |
Drawdown analysis of Drugs Made In America Acquisition II Corp - Units (1 Ord Shs & 1 Rts) (DMIIU)
The maximum drawdown for the DMIIU was -1.47%, occurring on Feb 12, 2026. Recovery took 79 trading sessions.
The current DMIIU drawdown is -0.83%.
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -1.47% | Jan 15, 2026 | 19 | Feb 12, 2026 | 79 | Jun 8, 2026 | 98 |
| -1.12% | Jun 8, 2026 | 1 | Jun 9, 2026 | Ongoing | Ongoing | Ongoing |
| -0.60% | Nov 3, 2025 | 33 | Dec 19, 2025 | 17 | Jan 15, 2026 | 50 |
| -0.45% | Sep 25, 2025 | 3 | Sep 30, 2025 | 11 | Oct 15, 2025 | 14 |
| -0.10% | Oct 15, 2025 | 1 | Oct 16, 2025 | 3 | Oct 21, 2025 | 4 |
| -0.10% | Oct 21, 2025 | 1 | Oct 22, 2025 | 3 | Oct 27, 2025 | 4 |